Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Adventures Through The Mind

Prohibition Fatalities and MDMA Complexities w/ Emanuel Sferios ~ Ep 44

27 Mar 2017

Description

Emanuel Sferios is an activist, educator and harm reduction advocate. Founding DanceSafe in 1998 and starting the first laboratory pill analysis program for ecstasy users that same year, Emanuel pioneered MDMA harm reduction services in the United States. He is currently producing a documentary on MDMA highlighting its use in therapy as well as harm reduction as a practical, rational alternative to three decades of failed efforts at prohibition. For the March new moon episode of Adventures Through The Mind Radio, Emanuel and I sat down to talk about MDMA: The Movie. However, our conversation rolled on rather quickly into unexpected waters as we discussed prohibition and the war on drugs. Increasingly more so it has become obvious that the so-called Drug War is only making things worse and that prohibition may very well be the cause of the fatal drug problems we see in the modern world. It was great to get Emanual's thoughts on this as a 20-year advocate for harm reduction. We also talk about: the early 90s rave scene, the use of MDMA-assisted psychotherapy for the resolution of PTSD, the early days of the DanceSafe harm reduction movement, the fatal consequences of prohibition functional heroin dependence, MDMA safety: tips and practices, Pharmacological hacks for ending MDMA hangover, mainstream media's manipulation of drug reporting to manufacture consent for a failing prohibition program AND MORE! Full Show Notes: http://bit.ly/ATTMindRadioEp44 Support The Podcast PayPal Donation Patreon Other Options (including bitcoin)

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.